Back to Search Start Over

Successful Management of Myval Transcatheter Heart Valve Embolization Into Abdominal Aortic Aneurysm During Transcatheter Aortic Valve Replacement.

Authors :
García-Escobar A
Galeote G
Jurado-Román A
Jiménez-Valero S
Cabrera JÁ
Moreno R
Source :
Texas Heart Institute journal [Tex Heart Inst J] 2024 Nov 05; Vol. 51 (2).
Publication Year :
2024

Abstract

Transcatheter heart valve embolization is a serious and rare complication of transcatheter aortic valve replacement. Having a strategy for promptly managing transcatheter heart valve embolization is crucial to avoid emergency conversion from transcatheter aortic valve replacement to open-heart surgery. Many cases of transcatheter heart valve embolization occurring with balloon-expandable prostheses such as the SAPIEN 3 (Edwards LifeSciences Corporation) valve and self-expandable prostheses such as the ACURATE neo (Boston Scientific Corporation) valve have been reported in the literature. Here, for the first time (to the authors' knowledge), the case of a Myval (Meril Life Sciences Pvt Ltd) transcatheter heart valve embolization during transcatheter aortic valve replacement, which was treated percutaneously with favorable outcomes, is reported.<br /> (© 2024 The Authors. Published by The Texas Heart Institute®.)

Details

Language :
English
ISSN :
1526-6702
Volume :
51
Issue :
2
Database :
MEDLINE
Journal :
Texas Heart Institute journal
Publication Type :
Academic Journal
Accession number :
39498628
Full Text :
https://doi.org/10.14503/THIJ-22-7997